STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Pivotal Response Treatment for Individuals With Intellectual Disabilities

Not Applicable

Completed

Conditions: Speech Delay
Intellectual Disabilities
Language Disorder

Interventions: Behavioral: Pivotal Response Treatment (PRT)

First Posted Date: 2013-11-20

Last Posted Date: 2021-01-12

Lead Sponsor: Stanford University

Target Recruit Count: 21

Registration Number: NCT01988623

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009

Phase 4

Completed

Conditions: Influenza

Interventions: Biological: Fluzone® (intramuscular)
Biological: FluMist® (intranasal)

First Posted Date: 2013-11-19

Last Posted Date: 2017-05-12

Lead Sponsor: Stanford University

Target Recruit Count: 72

Registration Number: NCT01987349

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")

Completed

Conditions: AIDS
HIV

Interventions: Behavioral: Neuropsychological testing

First Posted Date: 2013-11-15

Last Posted Date: 2016-10-17

Lead Sponsor: Stanford University

Target Recruit Count: 100

Registration Number: NCT01985399

Locations: 🇺🇸
Stanford University AIDS Clinical Trials Unit, Palo Alto, California, United States

Genome Transplant Dynamics: Non-invasive Sequencing-based Diagnosis of Rejection

Completed

Conditions: Lung Transplant Rejection
Cardiac Transplant Rejection

First Posted Date: 2013-11-15

Last Posted Date: 2019-10-04

Lead Sponsor: Stanford University

Target Recruit Count: 65

Registration Number: NCT01985412

Locations: 🇺🇸
Stanford University Hospital and Clinics, Stanford, California, United States
🇺🇸
Kaiser Permanente Northern California, Santa Clara, California, United States

Fibrinolysis Before Cardiopulmonary Bypass?

Phase 4

Completed

Conditions: Pathologic Fibrinolysis

Interventions: Drug: Epsilonaminocaproic acid
Drug: Placebo

First Posted Date: 2013-11-13

Last Posted Date: 2016-06-30

Lead Sponsor: Stanford University

Target Recruit Count: 40

Registration Number: NCT01981863

Locations: 🇺🇸
Stanford Hospital & Clinics, Stanford, California, United States

Clavicle Splint for Pain Reduction After Posterior Cervicothoracic Surgery

Not Applicable

Completed

Conditions: Posterior Cervical Surgery
Posterior Cervical Laminectomy
Posterior Cervical Laminoplasty
Posterior Cervical Fusion

Interventions: Device: Clavicle Brace

First Posted Date: 2013-11-07

Last Posted Date: 2017-08-21

Lead Sponsor: Stanford University

Target Recruit Count: 30

Registration Number: NCT01977690

Locations: 🇺🇸
Stanford University Hospital, Stanford, California, United States

High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases

Withdrawn

Conditions: Multiple Sclerosis

Interventions: Drug: Feraheme
Drug: Gadolinium-based contrast

First Posted Date: 2013-10-31

Last Posted Date: 2018-09-10

Lead Sponsor: Stanford University

Registration Number: NCT01973517

Locations: 🇺🇸
Richard M. Lucas Center for Imaging (of Stanford University), Stanford, California, United States
🇺🇸
Stanford Hospitals and Clinics, Stanford, California, United States

Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer

Completed

Conditions: Breast - Female

First Posted Date: 2013-10-28

Last Posted Date: 2018-04-17

Lead Sponsor: Stanford University

Target Recruit Count: 50

Registration Number: NCT01970670

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women

Phase 2

Completed

Conditions: Narcotic Addiction
Neonatal Abstinence Syndrome

Interventions: Drug: Placebo
Drug: Ondansetron

First Posted Date: 2013-10-18

Last Posted Date: 2022-06-07

Lead Sponsor: Stanford University

Target Recruit Count: 196

Registration Number: NCT01965704

Locations: 🇺🇸
University of Tennessee Health Science Center, Memphis, Tennessee, United States
🇺🇸
University of Louisville, Louisville, Kentucky, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States

and more 5 locations

The Role of Vasopressin in the Social Deficits of Autism

Phase 2

Completed

Conditions: Autism Spectrum Disorders

Interventions: Drug: Placebo
Drug: Vasopressin

First Posted Date: 2013-10-14

Last Posted Date: 2019-05-24

Lead Sponsor: Stanford University

Target Recruit Count: 68

Registration Number: NCT01962870

Locations: 🇺🇸
Stanford University School of Medicine; Psychiatry and Behavioral Sciences, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy